Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Life Sciences & Healthcare segment
product2 mentionslast seen Oct 13, 2026
Business unit of Clarivate providing life sciences and healthcare intelligence solutions.
Relationships 1
Relationship
AltarisacquiresLife Sciences & Healthcare segment
99% confidence2 supporting mentionsfrom Oct 6, 2026
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGAROct 13, 2026CLARIVATE PLC 8-K/A: Item 2.01: Completion of Acquisition or Disposition of Assets; Item 9.01: Financial Statements and Exhibits
Clarivate agreed to sell its Life Sciences and Healthcare business ("LS&H") to the Buyer (the "Transaction") for an aggregate purchase price of $600 million
- filingSEC EDGAROct 6, 2026CLARIVATE PLC 8-K: Item 2.01: Completion of Acquisition or Disposition of Assets; Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
completed the previously announced sale of its Life Sciences and Healthcare business to an affiliate of Altaris, LLC